EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced expression of immune response genes in neural cells with mutations in the PARK2 gene in Parkinson’s disease

V B Fedoseyeva, E V Novosadova, V V Nenasheva, L V Novosadova, I A Grivennikov, V Z Tarantul

Acta Naturae · 22.04.2026 · 18 (1) · 104-113

DOI: 10.32607/actanaturae.27664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Naturae, online erschienen am 22.04.2026. Verfasst von V B Fedoseyeva und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Research Center "Kurchatov Institute", Moscow, 123098 Russia. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is one of the most common chronic neurodegenerative diseases. PD is characterized by the dysfunction of multiple body functions caused by changes in the expression of a large number of genes. Current evidence suggests that changes in the innate immunity and neuroinflammation may play an important role in the pathogenesis of the disease. However, the exact mechanism through which immune dysfunction develops in the context of PD pathogenesis remains unclear. In this study, with the use of transcriptome sequencing (RNA-seq), followed by quantitative PCR, we managed to detect a differential expression of the genes involved in the immune activity in neural progenitors (NPs) and glial cells derived from induced pluripotent stem cells from healthy donors (HDs) and PD patients carrying mutations in the PARK2 gene. Expression of many of the genes involved in a number of innate immune signaling pathways (in particular, in the canonical NFκB, non-canonical NFκB, the TNFα/NFκB, IL6/STAT3, IL2/STAT5 pathways, as well as the IFNγ and IFNα response) in cells from PD patients was found to be reduced compared to that in the cells from healthy donors. A mechanism for regulating these signaling pathways in the neural precursors of PD patients carrying mutations in the PARK2 gene is proposed.

Schlagwörter

Stichwörter der Autor:innen

Parkinson’s diseasedifferential gene transcriptiongliainduced pluripotent stem cellsneural precursors

Autor:innen und Institutionen

  • National Research Center "Kurchatov Institute", Moscow, 123098 Russia.
  • Federal Research and Clinical Center for Physicochemical Medicine named after Academician Yu.M. Lopukhin, Federal Medical and Biological Agency, Moscow 119435 Russia.

Zitieren

APA

Fedoseyeva, V. B., Novosadova, E. V., Nenasheva, V. V., Novosadova, L. V., Grivennikov, I. A., & Tarantul, V. Z. (2026). Reduced expression of immune response genes in neural cells with mutations in the PARK2 gene in Parkinson’s disease. Acta Naturae, 18(1), 104-113. https://doi.org/10.32607/actanaturae.27664

Vancouver

Fedoseyeva VB, Novosadova EV, Nenasheva VV, Novosadova LV, Grivennikov IA, Tarantul VZ. Reduced expression of immune response genes in neural cells with mutations in the PARK2 gene in Parkinson’s disease. Acta Naturae. 2026;18(1):104-113. doi:10.32607/actanaturae.27664

BibTeX
@article{Fedoseyeva2026,
  author = {Fedoseyeva, V B and Novosadova, E V and Nenasheva, V V and Novosadova, L V and Grivennikov, I A and Tarantul, V Z},
  title = {Reduced expression of immune response genes in neural cells with mutations in the PARK2 gene in Parkinson’s disease},
  journal = {Acta Naturae},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {104--113},
  doi = {10.32607/actanaturae.27664}
}
Kostenlos starten →